Valina L. Dawson

107.8k total citations · 27 hit papers
380 papers, 56.5k citations indexed

About

Valina L. Dawson is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Valina L. Dawson has authored 380 papers receiving a total of 56.5k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Molecular Biology, 157 papers in Neurology and 145 papers in Cellular and Molecular Neuroscience. Recurrent topics in Valina L. Dawson's work include Parkinson's Disease Mechanisms and Treatments (151 papers), Nuclear Receptors and Signaling (66 papers) and Nitric Oxide and Endothelin Effects (52 papers). Valina L. Dawson is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (151 papers), Nuclear Receptors and Signaling (66 papers) and Nitric Oxide and Endothelin Effects (52 papers). Valina L. Dawson collaborates with scholars based in United States, Germany and South Korea. Valina L. Dawson's co-authors include Ted M. Dawson, Solomon H. Snyder, Darren J. Moore, Han Seok Ko, Andrew B. West, S H Snyder, Guy G. Poirier, Kenny K. K. Chung, Shaida A. Andrabi and Ted M. Dawson and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Valina L. Dawson

378 papers receiving 55.6k citations

Hit Papers

Nitric oxide mediates glutamate neurotoxicity in primary ... 1991 2026 2002 2014 1991 2002 2003 2009 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
    1991 1.9k citations Valina L. Dawson, Ted M. Dawson et al. Proceedings of the National Academy of Sciences profile →
  2. Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
    2002 1.5k citations Seong-Woon Yu, Hongmin Wang et al. Science profile →
  3. Molecular Pathways of Neurodegeneration in Parkinson's Disease
    2003 1.4k citations Ted M. Dawson, Valina L. Dawson Science profile →
  4. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
    2009 1.3k citations Cristòfol Vives-Bauzá, Chun Hui Zhou et al. Proceedings of the National Academy of Sciences profile →
  5. MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
    2005 1.0k citations Darren J. Moore, Valina L. Dawson et al. profile →
  6. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
    2019 961 citations Tae‐In Kam, Nikhil Panicker et al. profile →
  7. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
    2005 945 citations Darren J. Moore, Christopher A. Ross et al. Proceedings of the National Academy of Sciences profile →
  8. Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity
    1994 944 citations Valina L. Dawson, Ted M. Dawson et al. Science profile →
  9. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
    1999 888 citations Valina L. Dawson, Serge Przedborski et al. profile →
  10. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity
    2001 880 citations Frederick C. Nucifora, Juan C. Troncoso et al. Science profile →
  11. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
    1997 857 citations Mikael J. L. Eliasson, Valina L. Dawson et al. profile →
  12. PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
    2011 780 citations Joo‐Ho Shin, Han Seok Ko et al. Cell profile →
  13. Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
    2000 777 citations Kenny K. K. Chung, Valina L. Dawson et al. Proceedings of the National Academy of Sciences profile →
  14. A novel neuronal messenger molecule in brain: The free radical, nitric oxide
    1992 705 citations Ted M. Dawson, Valina L. Dawson et al. profile →
  15. S -Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function
    2004 636 citations Kenny K. K. Chung, Bobby Thomas et al. Science profile →
  16. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury.
    1996 618 citations Valina L. Dawson, Ted M. Dawson et al. Proceedings of the National Academy of Sciences profile →
  17. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death
    2006 612 citations Shaida A. Andrabi, Hongmin Wang et al. Proceedings of the National Academy of Sciences profile →
  18. Genetic Animal Models of Parkinson's Disease
    2010 602 citations Ted M. Dawson, Han Seok Ko et al. profile →
  19. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease
    2001 599 citations Kenny K. K. Chung, Valina L. Dawson et al. profile →
  20. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion
    1998 596 citations Valina L. Dawson et al. profile →
  21. Nitric Oxide Synthase in Models of Focal Ischemia
    1997 553 citations Ted M. Dawson, Valina L. Dawson et al. profile →
  22. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    1996 531 citations Serge Przedborski, Valina L. Dawson et al. Proceedings of the National Academy of Sciences profile →
  23. Poly(ADP-ribose) (PAR) polymer is a death signal
    2006 527 citations Shaida A. Andrabi, Hongmin Wang et al. Proceedings of the National Academy of Sciences profile →
  24. Kinase activity of mutant LRRK2 mediates neuronal toxicity
    2006 506 citations Valina L. Dawson, Ted M. Dawson et al. profile →
  25. Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities
    2013 443 citations Valina L. Dawson, Ted M. Dawson et al. profile →
  26. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
    2020 328 citations Valina L. Dawson, Ted M. Dawson et al. profile →
  27. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson’s disease
    2022 139 citations Nikhil Panicker, Tae‐In Kam et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valina L. Dawson United States 126 26.9k 18.4k 15.8k 12.9k 8.3k 380 56.5k
Ted M. Dawson United States 133 28.9k 1.1× 20.6k 1.1× 19.4k 1.2× 15.3k 1.2× 8.4k 1.0× 433 61.8k
Nobutaka Hattori Japan 90 15.5k 0.6× 19.7k 1.1× 10.6k 0.7× 7.5k 0.6× 5.8k 0.7× 1.1k 42.6k
Stuart A. Lipton United States 125 26.9k 1.0× 4.1k 0.2× 18.7k 1.2× 12.3k 1.0× 8.0k 1.0× 386 52.8k
Berislav V. Zloković United States 98 13.0k 0.5× 7.5k 0.4× 6.8k 0.4× 17.2k 1.3× 18.5k 2.2× 307 48.0k
Serge Przedborski United States 110 14.3k 0.5× 21.8k 1.2× 15.3k 1.0× 7.8k 0.6× 8.4k 1.0× 261 41.6k
Christian Haass Germany 112 24.0k 0.9× 10.0k 0.5× 9.7k 0.6× 29.7k 2.3× 7.0k 0.8× 384 49.9k
Isidró Ferrer Spain 101 20.4k 0.8× 8.3k 0.5× 11.4k 0.7× 12.8k 1.0× 7.7k 0.9× 910 42.1k
Virginia M.‐Y. Lee United States 161 34.2k 1.3× 43.8k 2.4× 24.0k 1.5× 48.2k 3.7× 19.6k 2.4× 668 97.8k
Richard J. Youle United States 103 43.9k 1.6× 7.4k 0.4× 4.8k 0.3× 7.5k 0.6× 2.3k 0.3× 239 63.1k
Michel Goedert United Kingdom 130 28.8k 1.1× 18.9k 1.0× 18.2k 1.1× 39.3k 3.0× 11.8k 1.4× 394 64.2k

Countries citing papers authored by Valina L. Dawson

Since Specialization
Citations

This map shows the geographic impact of Valina L. Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valina L. Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valina L. Dawson more than expected).

Fields of papers citing papers by Valina L. Dawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valina L. Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valina L. Dawson. The network helps show where Valina L. Dawson may publish in the future.

Co-authorship network of co-authors of Valina L. Dawson

This figure shows the co-authorship network connecting the top 25 collaborators of Valina L. Dawson. A scholar is included among the top collaborators of Valina L. Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valina L. Dawson. Valina L. Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qinfang, Bingxu Huang, Dong Zhu, et al.. (2024). CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration. Science Advances. 10(47). eadn5417–eadn5417. 1 indexed citations
2.
Kang, Hojin, Areum Jo, Xiaobo Mao, et al.. (2023). PARIS undergoes liquid–liquid phase separation and poly( ADP ‐ribose)‐mediated solidification. EMBO Reports. 24(11). e56166–e56166. 6 indexed citations
3.
Dawson, Valina L., et al.. (2023). DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease. Journal of Parkinson s Disease. 13(2). 145–164. 16 indexed citations
4.
Pirooznia, Sheila K., Hu Wang, Nikhil Panicker, et al.. (2022). Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson’s disease. Science Advances. 8(13). eabh1824–eabh1824. 21 indexed citations
5.
Hinkle, Jared T., Jaimin Patel, Nikhil Panicker, et al.. (2022). STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy. Proceedings of the National Academy of Sciences. 119(15). e2118819119–e2118819119. 138 indexed citations
6.
Kim, Jae Jin, Seo Yun Lee, Soyeon Kim, et al.. (2021). USP39 promotes non-homologous end-joining repair by poly(ADP-ribose)-induced liquid demixing. Nucleic Acids Research. 49(19). 11083–11102. 17 indexed citations
7.
Piard, Juliette, George K. E. Umanah, Frederike L. Harms, et al.. (2017). A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy. Brain. 141(3). 651–661. 35 indexed citations
8.
Zhang, Jianmin, Huaishan Wang, Omar Sherbini, et al.. (2016). High-Content Genome-Wide RNAi Screen RevealsCCR3as a Key Mediator of Neuronal Cell Death. eNeuro. 3(5). ENEURO.0185–16.2016. 19 indexed citations
9.
Kageyama, Yusuke, Masahiko Hoshijima, Kinya Seo, et al.. (2014). Parkin‐independent mitophagy requires D rp1 and maintains the integrity of mammalian heart and brain. The EMBO Journal. 33(23). 2798–2813. 356 indexed citations
10.
Chen, Yuchan, George K. E. Umanah, Noah Dephoure, et al.. (2014). M sp1/ ATAD 1 maintains mitochondrial function by facilitating the degradation of mislocalized tail‐anchored proteins. The EMBO Journal. 33(14). 1548–1564. 167 indexed citations
11.
Lee, Yun-Il, Ho Chul Kang, Yunjong Lee, et al.. (2013). Protein Microarray Characterization of the S-Nitrosoproteome. Molecular & Cellular Proteomics. 13(1). 63–72. 50 indexed citations
12.
Tsang, Anthony H., Han Seok Ko, Joseph M. Savitt, et al.. (2009). S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proceedings of the National Academy of Sciences. 106(12). 4900–4905. 125 indexed citations
13.
Vives-Bauzá, Cristòfol, Chun Hui Zhou, Yong Huang, et al.. (2009). PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proceedings of the National Academy of Sciences. 107(1). 378–383. 1321 indexed citations breakdown →
14.
Eacker, Stephen, Ted M. Dawson, & Valina L. Dawson. (2009). Understanding microRNAs in neurodegeneration. Nature reviews. Neuroscience. 10(12). 837–841. 240 indexed citations
15.
Shin, Joo‐Ho, Valina L. Dawson, & Ted M. Dawson. (2009). SnapShot: Pathogenesis of Parkinson's Disease. Cell. 139(2). 440.e1–440.e2. 13 indexed citations
16.
Hara, Makoto R., Bobby Thomas, Matthew B. Cascio, et al.. (2006). Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proceedings of the National Academy of Sciences. 103(10). 3887–3889. 191 indexed citations
17.
Zhang, Li, Valina L. Dawson, & Ted M. Dawson. (2005). Role of nitric oxide in Parkinson's disease. Pharmacology & Therapeutics. 109(1-2). 33–41. 154 indexed citations
18.
Nucifora, Frederick C., Lisa Ellerby, Cheryl L. Wellington, et al.. (2003). Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity. Journal of Biological Chemistry. 278(15). 13047–13055. 68 indexed citations
19.
Yu, Seong-Woon, Hongmin Wang, Marc F. Poitras, et al.. (2002). Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor. Science. 297(5579). 259–263. 1523 indexed citations breakdown →
20.
Kriegsfeld, Lance J., Mikael J. L. Eliasson, Gregory E. Demas, et al.. (1999). Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice. Neuroscience. 89(2). 311–315. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ted M. Dawson Breakdown of academic impact, for papers by Nobutaka Hattori Breakdown of academic impact, for papers by Stuart A. Lipton Breakdown of academic impact, for papers by Berislav V. Zloković Breakdown of academic impact, for papers by Serge Przedborski Breakdown of academic impact, for papers by Christian Haass Breakdown of academic impact, for papers by Isidró Ferrer Breakdown of academic impact, for papers by Virginia M.‐Y. Lee Breakdown of academic impact, for papers by Richard J. Youle Breakdown of academic impact, for papers by Michel Goedert
Rankless by CCL
2026